Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	IgG immunoglobulin complex	IGLC2 IGLC3 IGLC6	4.89e-06	14	51	3	GO:0071735
GeneOntologyCellularComponent	immunoglobulin complex	IGLC2 IGLC3 IGLC6 IGLV5-45 IGLV5-39	5.20e-05	166	51	5	GO:0019814
GeneOntologyCellularComponent	IgD immunoglobulin complex	IGLC3 IGLC6	8.70e-05	6	51	2	GO:0071738
GeneOntologyCellularComponent	IgE immunoglobulin complex	IGLC3 IGLC6	8.70e-05	6	51	2	GO:0071742
GeneOntologyCellularComponent	chromatin	ATXN7L3 HOXC8 HOXD10 MAX POLR2A BICRAL FOXN3 MED1 SPRTN HSF2 OBI1 AFF4	1.81e-04	1480	51	12	GO:0000785
GeneOntologyCellularComponent	IgA immunoglobulin complex	IGLC3 IGLC6	6.00e-04	15	51	2	GO:0071745
GeneOntologyCellularComponent	IgM immunoglobulin complex	IGLC3 IGLC6	6.00e-04	15	51	2	GO:0071753
Domain	ZU5	ANK3 TJP1	2.30e-04	9	48	2	SM00218
Domain	ZU5	ANK3 TJP1	2.87e-04	10	48	2	PS51145
Domain	ZU5	ANK3 TJP1	4.20e-04	12	48	2	PF00791
Domain	ZU5_dom	ANK3 TJP1	4.20e-04	12	48	2	IPR000906
Domain	HMG_BOX_2	PMS1 WDHD1	8.50e-03	54	48	2	PS50118
Domain	HMG	PMS1 WDHD1	8.50e-03	54	48	2	SM00398
Domain	-	PMS1 WDHD1	8.81e-03	55	48	2	1.10.30.10
Domain	HMG_box_dom	PMS1 WDHD1	1.21e-02	65	48	2	IPR009071
Pubmed	Human immunoglobulin C lambda 6 gene encodes the Kern+Oz-lambda chain and C lambda 4 and C lambda 5 are pseudogenes.	IGLC2 IGLC3 IGLC6	1.86e-07	8	53	3	3122211
Pubmed	Clustered arrangement of immunoglobulin lambda constant region genes in man.	IGLC2 IGLC3 IGLC6	2.79e-07	9	53	3	6273747
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	PMS1 UBN1 MAX ZNF280C MED1 TRIP12 ZBTB24 DNTTIP2 AFF4	3.21e-07	608	53	9	36089195
Pubmed	Physicochemical and functional characterization of the C1r subunit of the first complement component.	IGLC2 IGLC3 IGLC6 IGLV5-45	8.16e-07	47	53	4	814163
Pubmed	Recognition of immunoglobulins by Fcgamma receptors.	IGLC2 IGLC3 IGLC6 IGLV5-45	8.90e-07	48	53	4	11955599
Pubmed	Structure and function of immunoglobulins.	IGLC2 IGLC3 IGLC6	1.50e-06	15	53	3	20176268
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	PMS1 UBN1 TJP1 POLR2A ZNF280C HNRNPUL1 MED1 TRIP12 DNTTIP2 AFF4	1.54e-06	954	53	10	36373674
Pubmed	PAK5 kinase is an inhibitor of MARK/Par-1, which leads to stable microtubules and dynamic actin.	PAK5 MARK2	2.28e-06	2	53	2	16014608
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CYLD BMX TJP1 EXPH5 PAK5 MARK2 HNRNPUL1 TRIP12 OBI1	5.60e-06	861	53	9	36931259
Pubmed	Identification of new interacting partners of the shuttling protein ubinuclein (Ubn-1).	UBN1 TJP1	6.83e-06	3	53	2	22245583
Pubmed	Mediator and post-recruitment regulation of RNA polymerase II.	POLR2A MED1	6.83e-06	3	53	2	21326907
Pubmed	Accurate balance of the polarity kinase MARK2/Par-1 is required for proper cortical neuronal migration.	PAK5 MARK2	6.83e-06	3	53	2	18509032
Pubmed	Lateral membrane biogenesis in human bronchial epithelial cells requires 190-kDa ankyrin-G.	ANK3 TJP1	6.83e-06	3	53	2	14757759
Pubmed	Unraveling of the polymorphic C lambda 2-C lambda 3 amplification and the Ke+Oz- polymorphism in the human Ig lambda locus.	IGLC2 IGLC3	6.83e-06	3	53	2	12077254
Pubmed	Three-dimensional structure of a light chain dimer crystallized in water. Conformational flexibility of a molecule in two crystal forms.	IGLC2 IGLC3	6.83e-06	3	53	2	2515285
Pubmed	Activator-mediator binding stabilizes RNA polymerase II orientation within the human mediator-RNA polymerase II-TFIIF assembly.	POLR2A MED1	6.83e-06	3	53	2	22343046
Pubmed	HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.	HOXC8 HOXD10	6.83e-06	3	53	2	27658780
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	PMS1 TJP1 POLR2A ZNF280C HNRNPUL1 MED1 DHX29 DNTTIP2 AFF4	1.07e-05	934	53	9	33916271
Pubmed	Characterization of the ubinuclein protein as a new member of the nuclear and adhesion complex components (NACos).	UBN1 TJP1	1.36e-05	4	53	2	18823282
Pubmed	Asymmetric distribution of PAR proteins in the mouse embryo begins at the 8-cell stage during compaction.	TJP1 MARK2	1.36e-05	4	53	2	15950600
Pubmed	[Structural rule of antibodies. Primary structure of a monoclonal immunoglobulin-L-chain of the lambda type, subgroup IV (Bence-Jones-protein Kern). V. The complete amino acid sequence and its genetic interpretation].	IGLC2 IGLC3	1.36e-05	4	53	2	5549568
Pubmed	Comparative studies on the structure of the light chains of human immunoglobulins. IV. Assignment of a subsubgroup.	IGLC2 IGLC3	1.36e-05	4	53	2	6404900
Pubmed	The three-dimensional structure of the fab' fragment of a human myeloma immunoglobulin at 2.0-angstrom resolution.	IGLC2 IGLC3	1.36e-05	4	53	2	4215080
Pubmed	Primary structure of the Mcg lambda chain.	IGLC2 IGLC3	1.36e-05	4	53	2	4415202
Pubmed	Immunoglobulin lambda-chains. The complete amino acid sequence of a Bence-Jones protein.	IGLC2 IGLC3	1.36e-05	4	53	2	4883841
Pubmed	Hox-3.6: isolation and characterization of a new murine homeobox gene located in the 5' region of the Hox-3 cluster.	HOXC8 HOXD10	1.36e-05	4	53	2	1353983
Pubmed	Placing the HIRA histone chaperone complex in the chromatin landscape.	UBN1 MAX POLR2A	1.46e-05	31	53	3	23602572
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	UBN1 WDHD1 POLR2A MARK2 HNRNPUL1 MED1 TRIP12 DHX29	2.12e-05	774	53	8	15302935
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	CYLD CDKL5 ATP7A ANK3 TJP1 GPRC5C HNRNPUL1 TRIP12	2.18e-05	777	53	8	35844135
Pubmed	Reproductive cycle regulation of nuclear import, euchromatic localization, and association with components of Pol II mediator of a mammalian double-bromodomain protein.	POLR2A MED1	2.27e-05	5	53	2	12145330
Pubmed	Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter.	POLR2A MED1	2.27e-05	5	53	2	15863722
Pubmed	Binding of liganded vitamin D receptor to the vitamin D receptor interacting protein coactivator complex induces interaction with RNA polymerase II holoenzyme.	POLR2A MED1	2.27e-05	5	53	2	10753860
Pubmed	Amino acid sequence of the (lambda) light chain of a human myeloma immunoglobulin (IgG New).	IGLC2 IGLC3	2.27e-05	5	53	2	4814727
Pubmed	The amino acid sequence of a lambda type Bence-Jones protein. 3. The complete amino acid sequence and the location of the disulfide bridges.	IGLC2 IGLC3	2.27e-05	5	53	2	4909564
Pubmed	Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha,25-Dihydroxyvitamin D3.	POLR2A MED1	3.40e-05	6	53	2	15919092
Pubmed	Activation of C1r by proteolytic cleavage.	IGLC2 IGLC3 IGLV5-45	3.95e-05	43	53	3	1249422
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	CYLD UBN1 POLR2A PSMD10 MED1 TRIP12 ZBTB24	5.37e-05	645	53	7	25281560
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	POLR2A HNRNPUL1 MED1 TRIP12 DHX29 DNTTIP2	5.50e-05	440	53	6	34244565
Pubmed	Characterization of the two unique human anti-flavin monoclonal immunoglobulins.	IGLC2 IGLC3	6.34e-05	8	53	2	7737190
Pubmed	Dynamics of histone H3 deposition in vivo reveal a nucleosome gap-filling mechanism for H3.3 to maintain chromatin integrity.	UBN1 POLR2A	6.34e-05	8	53	2	22195966
Pubmed	Human Polymerase-Associated Factor complex (PAFc) connects the Super Elongation Complex (SEC) to RNA polymerase II on chromatin.	POLR2A AFF4	6.34e-05	8	53	2	21873227
Pubmed	A census of human transcription factors: function, expression and evolution.	HOXC8 WDHD1 HOXD10 MAX FOXN3 HSF2 ZBTB24 ZBTB14	6.56e-05	908	53	8	19274049
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	ZNF280C MED1 TRIP12 DNTTIP2 AFF4	7.18e-05	283	53	5	30585729
Pubmed	Discovery and Characterization of ZUFSP/ZUP1, a Distinct Deubiquitinase Class Important for Genome Stability.	CYLD ATXN7L3 WDHD1 TJP1	7.64e-05	147	53	4	29576527
Pubmed	HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.	ZNF280C HNRNPUL1 DNTTIP2 AFF4	7.84e-05	148	53	4	32538781
Pubmed	Integrator, a multiprotein mediator of small nuclear RNA processing, associates with the C-terminal repeat of RNA polymerase II.	POLR2A PSMD10 MED1	7.84e-05	54	53	3	16239144
Pubmed	Live imaging of heart tube development in mouse reveals alternating phases of cardiac differentiation and morphogenesis.	TJP1 POLR2A	8.15e-05	9	53	2	29202929
Pubmed	Structure and expression of the human immunoglobulin lambda genes.	IGLC2 IGLC3	8.15e-05	9	53	2	2115572
Pubmed	Atypical protein kinase C is involved in the evolutionarily conserved par protein complex and plays a critical role in establishing epithelia-specific junctional structures.	TJP1 MARK2	8.15e-05	9	53	2	11257119
Pubmed	The protein interaction landscape of the human CMGC kinase group.	CDKL5 LAMA1 FOXN3 MED1 RBM23 OBI1 AFF4	8.57e-05	695	53	7	23602568
Pubmed	A human MAP kinase interactome.	ANK3 EXPH5 MAX PAK5 BICRAL OBI1	9.50e-05	486	53	6	20936779
Pubmed	EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis.	MAX POLR2A	1.02e-04	10	53	2	35210568
Pubmed	Cooperation of nectin-1 and nectin-3 is required for normal ameloblast function and crown shape development in mouse teeth.	TJP1 LAMA1	1.24e-04	11	53	2	21038445
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	ATXN7L3 UBN1 MAX POLR2A HNRNPUL1 MED1 TRIP12 DNTTIP2 ZBTB14	1.35e-04	1294	53	9	30804502
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	MARK2 HNRNPUL1 MED1 HSF2 TRIP12 DHX29 DNTTIP2	1.48e-04	759	53	7	35915203
Pubmed	Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.	TJP1 POLR2A TRIP12 DHX29 DNTTIP2	1.52e-04	332	53	5	25693804
Pubmed	The cell-cycle regulator geminin inhibits Hox function through direct and polycomb-mediated interactions.	HOXC8 HOXD10	1.76e-04	13	53	2	14973489
Pubmed	Human mediator subunit MED26 functions as a docking site for transcription elongation factors.	POLR2A MED1 AFF4	1.93e-04	73	53	3	21729782
Pubmed	Epithelial Migration and Non-adhesive Periderm Are Required for Digit Separation during Mammalian Development.	TJP1 LAMA1	2.05e-04	14	53	2	32109382
Pubmed	A novel human SRB/MED-containing cofactor complex, SMCC, involved in transcription regulation.	POLR2A MED1	2.05e-04	14	53	2	10024883
Pubmed	Cold/menthol TRPM8 receptors initiate the cold-shock response and protect germ cells from cold-shock-induced oxidation.	UCP3 HSF2	2.05e-04	14	53	2	27317670
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	CYLD ANK3 WDHD1 PSMD10 TRIP12 ZBTB24 DNTTIP2 AFF4	2.22e-04	1084	53	8	11544199
Pubmed	Ankyrin-G regulated epithelial phenotype is required for mouse lens morphogenesis and growth.	ANK3 TJP1	2.36e-04	15	53	2	30562487
Pubmed	Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus.	HOXC8 POLR2A	2.36e-04	15	53	2	14992727
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	CYLD UBN1 MAX SPRTN HSF2 OBI1	2.66e-04	588	53	6	38580884
Pubmed	Identification of a Hoxd10-regulated transcriptional network and combinatorial interactions with Hoxa10 during spinal cord development.	HOXD10 TJP1	2.70e-04	16	53	2	14743444
Pubmed	The type I BMP receptors, Bmpr1a and Acvr1, activate multiple signaling pathways to regulate lens formation.	TJP1 LAMA1	2.70e-04	16	53	2	19733164
Pubmed	Laminin alpha5 is necessary for submandibular gland epithelial morphogenesis and influences FGFR expression through beta1 integrin signaling.	TJP1 LAMA1	2.70e-04	16	53	2	17601529
Pubmed	The transcription factor Rreb1 regulates epithelial architecture, invasiveness, and vasculogenesis in early mouse embryos.	TJP1 LAMA1	2.70e-04	16	53	2	33929320
Pubmed	EMC3 Is Essential for Retinal Organization and Neurogenesis During Mouse Retinal Development.	TJP1 POLR2A	2.70e-04	16	53	2	33605987
Pubmed	Hox genes and the evolution of vertebrate axial morphology.	HOXC8 HOXD10	2.70e-04	16	53	2	7768176
Pubmed	Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects.	HOXD10 BST1 LAMA1 MED1	3.00e-04	210	53	4	16537572
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	WDHD1 MAX POLR2A CHSY1 FOXN3 TRIP12 OBI1	3.09e-04	857	53	7	25609649
Pubmed	Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor.	MED1 TRIP12	3.43e-04	18	53	2	7776974
Pubmed	The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation.	POLR2A AFF4	3.43e-04	18	53	2	23087374
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	PMS1 HOXD10 MAX POLR2A HNRNPUL1 MED1 ZBTB24	3.56e-04	877	53	7	20211142
Pubmed	Plzf regulates limb and axial skeletal patterning.	HOXC8 HOXD10	3.83e-04	19	53	2	10835630
Pubmed	Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms.	TJP1 MARK2	4.25e-04	20	53	2	18227155
Pubmed	HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription.	POLR2A AFF4	4.25e-04	20	53	2	20471948
Pubmed	Shotgun proteomics reveals specific modulated protein patterns in tears of patients with primary open angle glaucoma naïve to therapy.	IGLC2 IGLC3 IGLC6	4.32e-04	96	53	3	23580065
Pubmed	Organization of human class I homeobox genes.	HOXC8 HOXD10	5.16e-04	22	53	2	2576652
Pubmed	The Role of RNA Polymerase II Elongation Control in HIV-1 Gene Expression, Replication, and Latency.	POLR2A AFF4	5.16e-04	22	53	2	22567366
Pubmed	Protein tyrosine phosphatase receptor delta acts as a neuroblastoma tumor suppressor by destabilizing the aurora kinase A oncogene.	BMX MARK2	5.16e-04	22	53	2	22305495
Pubmed	New insights into the control of HIV-1 transcription: when Tat meets the 7SK snRNP and super elongation complex (SEC).	POLR2A AFF4	5.65e-04	23	53	2	21360054
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	PMS1 UBN1 TJP1 MED1 DNTTIP2	5.75e-04	444	53	5	34795231
Pubmed	ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes.	POLR2A MARK2 MED1	5.93e-04	107	53	3	20508642
Pubmed	One-megabase sequence analysis of the human immunoglobulin lambda gene locus.	IGLC2 IGLC3 IGLV5-45	6.26e-04	109	53	3	9074928
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	MAX POLR2A PAK5 PSMD10 MARK2 HNRNPUL1 OBI1 ZBTB24	6.83e-04	1284	53	8	17353931
Pubmed	Elongin A regulates transcription in vivo through enhanced RNA polymerase processivity.	POLR2A AFF4	7.23e-04	26	53	2	33298525
Pubmed	Evidence that autocrine signaling through Bmpr1a regulates the proliferation, survival and morphogenetic behavior of distal lung epithelial cells.	ANK3 TJP1	7.23e-04	26	53	2	16414041
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	MAX POLR2A ZNF280C HNRNPUL1 TRIP12 DNTTIP2 AFF4	7.26e-04	989	53	7	36424410
Pubmed	Roles and functions of HIV-1 Tat protein in the CNS: an overview.	TJP1 POLR2A	7.80e-04	27	53	2	24359561
Pubmed	DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC.	MAX HNRNPUL1 ZBTB24	7.88e-04	118	53	3	37105989
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	ATP7A WDHD1 TJP1 MAX MARK2 HNRNPUL1 DNTTIP2	8.07e-04	1007	53	7	34597346
Pubmed	An Interaction Landscape of Ubiquitin Signaling.	CYLD LAMA1 PSMD10 SPRTN TRIP12	8.24e-04	481	53	5	28190767
Pubmed	Structure and evolution of the Smith-Magenis syndrome repeat gene clusters, SMS-REPs.	CCDC144CP CCDC144A	9.01e-04	29	53	2	11997339
Pubmed	The human HOX gene family.	HOXC8 HOXD10	9.01e-04	29	53	2	2574852
Pubmed	Dynamic MAPK/ERK Activity Sustains Nephron Progenitors through Niche Regulation and Primes Precursors for Differentiation.	TJP1 LAMA1	9.01e-04	29	53	2	30220628
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	ANK3 EXPH5 POLR2A MARK2 TRIP12	9.53e-04	497	53	5	36774506
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	TJP1 POLR2A TRIP12 DHX29 OBI1	9.62e-04	498	53	5	36634849
Cytoband	22q11.2	IGLC2 IGLC3 IGLC6 IGLV5-45 IGLV5-39	2.91e-07	120	53	5	22q11.2
Cytoband	Ensembl 112 genes in cytogenetic band chr22q11	IGLC2 IGLC3 IGLC6 IGLV5-45	1.41e-03	419	53	4	chr22q11
GeneFamily	Immunoglobulin lambda locus at 22q11.2	IGLC2 IGLC3 IGLC6 IGLV5-45 IGLV5-39	8.62e-07	89	36	5	353
ToppCell	IPF-Lymphoid-B_Plasma\|World / Disease state, Lineage and Cell class	IGLC2 IGLC3 IGLC6 CCDC144CP CCDC144A	1.94e-06	176	52	5	cc0cab6487df6867b529596ec94f55d31aa6ca36
ToppCell	IPF-Lymphoid-B_Plasma\|Lymphoid / Disease state, Lineage and Cell class	IGLC2 IGLC3 IGLC6 CCDC144CP CCDC144A	2.54e-06	186	52	5	f9c21daf905d0bb0e0e769ca4bb069ea4b1ba25b
ToppCell	COVID-19_Severe\|World / Disease condition and Cell class	CYLD ANK3 IGLC2 IGLC3 DNTTIP2	3.28e-06	196	52	5	450ac2aff89c5ca73b8bfbc80663e03be066931f
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	CYLD IGLC2 IGLC3 DNTTIP2 AFF4	3.62e-06	200	52	5	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	Striatum-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)\|Striatum / BrainAtlas - Mouse McCarroll V32	BMX SHE IGLC2 IGLC3	5.51e-06	99	52	4	0d5684978f34258d4eb4941eb6c60393a9bc84ed
ToppCell	Striatum-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)--\|Striatum / BrainAtlas - Mouse McCarroll V32	BMX SHE IGLC2 IGLC3	5.51e-06	99	52	4	1244f50bb66eea555a284ff5c35ac755d1e9080d
ToppCell	Striatum-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)-\|Striatum / BrainAtlas - Mouse McCarroll V32	BMX SHE IGLC2 IGLC3	5.51e-06	99	52	4	0c27df8ecc1956b056930da9ab1c96df7fb9f7b5
ToppCell	Transplant_Alveoli_and_parenchyma-Immune-B_cells\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	IGLC2 IGLC3 IGLC6 IGLV5-45	2.48e-05	145	52	4	34cff6df39ff05995041f0c231c60a50ad1a0c1c
ToppCell	metastatic_Lymph_Node-T/NK_cells-CD8_low_T\|T/NK_cells / Location, Cell class and cell subclass	TJP1 LAMA1 SHE SPRTN	2.69e-05	148	52	4	db046a02a00829910bf9d7dbda068e730aa78f00
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-9\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGLC2 IGLC3 IGLC6 IGLV5-45	2.91e-05	151	52	4	2314c004434aed9b7fa1ad01c61c43e5ed4a18ce
ToppCell	tumor_Lymph_Node_/_Brain-B_lymphocytes-Undetermined\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	UCP3 IGLC2 ZBTB24 CCDC144A	3.14e-05	154	52	4	e16f200391537aa1002b0079481b94e1fb86b9ad
ToppCell	390C-Lymphocytic-Plasma_cell\|390C / Donor, Lineage, Cell class and subclass (all cells)	IGLC2 IGLC3 IGLC6 CCDC144A	3.31e-05	156	52	4	0de2fc695bd5f8d4633c514f71ea941c88137bac
ToppCell	390C-Lymphocytic-Plasma_cell-\|390C / Donor, Lineage, Cell class and subclass (all cells)	IGLC2 IGLC3 IGLC6 CCDC144A	3.31e-05	156	52	4	4f92ca30755430db44402afc603d1ecd8bfc3617
ToppCell	normal_Lung-B_lymphocytes-MALT_B_cells\|normal_Lung / Location, Cell class and cell subclass	IGLC2 IGLC3 IGLC6 IGLV5-45	3.56e-05	159	52	4	fbd0131b66f4267f7b0d6c3ad874ad097b859074
ToppCell	tumor_Lymph_Node_/_Brain-B_lymphocytes-MALT_B_cells\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	IGLC2 IGLC3 IGLV5-45 CCDC144A	3.56e-05	159	52	4	204e5a675f4684c9570c24c8d34bbf632fd8164a
ToppCell	3'_v3-Lung-Lymphocytic_B_plasma-Plasma_cells\|Lung / Manually curated celltypes from each tissue	IGLC2 IGLC3 IGLC6 IGLV5-45	4.02e-05	164	52	4	3b6a32ba53d05f6818fe950ac426f489383b645a
ToppCell	390C-Lymphocytic-Plasma_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TJP1 IGLC2 IGLC6 CCDC144A	4.21e-05	166	52	4	4ba3711a02d3695b27f7cefd7c60e3be009f5bef
ToppCell	390C-Lymphocytic-Plasma_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TJP1 IGLC2 IGLC6 CCDC144A	4.21e-05	166	52	4	35f6ae2664935dda0d883b32a050ced843204f2d
ToppCell	367C-Lymphocytic-Plasma_cell-\|367C / Donor, Lineage, Cell class and subclass (all cells)	IGLC2 IGLC3 IGLC6 IGLV5-45	4.31e-05	167	52	4	f2185eb72f0137136f6d71af2a70168fded6c940
ToppCell	367C-Lymphocytic-Plasma_cell\|367C / Donor, Lineage, Cell class and subclass (all cells)	IGLC2 IGLC3 IGLC6 IGLV5-45	4.31e-05	167	52	4	5e768cf24699893e05d1bcb1c92dba2336943a64
ToppCell	Control-Lymphoid-B_Plasma\|Control / Disease state, Lineage and Cell class	IGLC2 IGLC3 IGLC6 IGLV5-45	4.84e-05	172	52	4	61e33836b8cb0f347f3e699eb587a37073b6fa4c
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGLC2 IGLC3 IGLC6 IGLV5-45	4.95e-05	173	52	4	0ca2169a275404118038c0489a48062879488765
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGLC2 IGLC3 IGLC6 IGLV5-45	4.95e-05	173	52	4	7e6bfe85f60834f317941b70d6e0dc3bd527d293
ToppCell	COPD-Lymphoid-B_Plasma\|World / Disease state, Lineage and Cell class	IGLC2 IGLC3 IGLC6 IGLV5-45	5.18e-05	175	52	4	d73ee324479172501481b54967a0f3bd870fcf3a
ToppCell	metastatic_Brain-B_lymphocytes-MALT_B_cells\|metastatic_Brain / Location, Cell class and cell subclass	IGLC2 IGLC3 IGLC6 IGLV5-45	5.29e-05	176	52	4	50e207403d48ce1b55a78897adb5519a2430a626
ToppCell	IPF-Lymphoid-B_Plasma\|IPF / Disease state, Lineage and Cell class	IGLC2 IGLC3 IGLC6 CCDC144CP	5.29e-05	176	52	4	e4f33f6cd140dd4fa3002bcd65ac8005d27865d1
ToppCell	COPD-Lymphoid-B_Plasma\|COPD / Disease state, Lineage and Cell class	IGLC2 IGLC3 IGLC6 IGLV5-45	5.41e-05	177	52	4	1b872d3b1e0fca138362098590a634d748dfca60
ToppCell	tumor_Lung-B_lymphocytes-MALT_B_cells\|tumor_Lung / Location, Cell class and cell subclass	IGLC2 IGLC3 IGLC6 CCDC144A	5.41e-05	177	52	4	37e03f51925345f5f716ef3abe1d2c4ccf129020
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IGLC2 IGLC3 IGLC6 IGLV5-45	5.53e-05	178	52	4	693f1135d9c5545945e80c7ba3d098afc0ccac29
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IGLC2 IGLC3 IGLC6 IGLV5-45	5.53e-05	178	52	4	6765c6970b1f2b719a20d2afd7471e1c262f3fc4
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGLC2 IGLC3 IGLC6 IGLV5-45	5.77e-05	180	52	4	cea079bc02e08c46600eed05ab9924ec90e1e3d3
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGLC2 IGLC3 IGLC6 CCDC144A	5.77e-05	180	52	4	588461d603dafa74e274a1dea021fd568e7f7875
ToppCell	356C-Lymphocytic-Plasma_cell\|356C / Donor, Lineage, Cell class and subclass (all cells)	IGLC2 IGLC3 IGLC6 IGLV5-45	5.90e-05	181	52	4	f1d88b83a13acd1c8e6b9ff8bd0acaff3650ceef
ToppCell	356C-Lymphocytic-Plasma_cell-\|356C / Donor, Lineage, Cell class and subclass (all cells)	IGLC2 IGLC3 IGLC6 IGLV5-45	5.90e-05	181	52	4	70cd612706640d8ebf0e047582b1daa2c1121526
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGLC2 IGLC3 IGLC6 IGLV5-45	6.03e-05	182	52	4	1bf2e4fd6222b41a7d08df6dcc500c9401db8c18
ToppCell	cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGLC2 IGLC3 IGLC6 IGLV5-45	6.16e-05	183	52	4	5ab4aa0304b832f98fff89b6c24ad5b7dd014c11
ToppCell	wk_20-22-Hematologic_Lymphocytic-B-CD5+_CCL22+_mature_B\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	IGLC2 IGLC3 IGLC6 IGLV5-45	6.29e-05	184	52	4	5bb775253a10a14360b06a46aba46d162a9bd1f8
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGLC2 IGLC3 IGLC6 IGLV5-45	6.29e-05	184	52	4	15f2c10101ccc8ed059520fc082ee42593dff269
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGLC2 IGLC3 IGLC6 IGLV5-45	6.29e-05	184	52	4	a90a58d9e319afa1cd572e4c2f516fadc42f56e5
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGLC2 IGLC3 IGLC6 IGLV5-45	6.42e-05	185	52	4	6ec009e48e50471c28e914c402f500e56a88f8f2
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGLC2 IGLC3 IGLC6 IGLV5-45	6.42e-05	185	52	4	f49ad6401b2abd089e30eba245b11b5031ea2318
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX TJP1 SHE HNRNPUL1	6.56e-05	186	52	4	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	tumor_Lung-Endothelial_cells-Lymphatic_ECs\|tumor_Lung / Location, Cell class and cell subclass	BMX HOXD10 SHE TM4SF18	6.69e-05	187	52	4	87ecdc5f24aced95a37e653429f0fc493ff4aa3e
ToppCell	3'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGLC2 IGLC3 IGLC6 IGLV5-45	6.83e-05	188	52	4	8e1220066008aef171692c6afffcf31833a3fae8
ToppCell	3'-Adult-LargeIntestine-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGLC2 IGLC3 IGLC6 IGLV5-45	6.83e-05	188	52	4	31d7e62cce010eed1c2db6d6eb55806d27b26151
ToppCell	356C-Lymphocytic-Plasma_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	IGLC2 IGLC3 IGLC6 IGLV5-45	6.98e-05	189	52	4	d1bd3b5ac32459929e556fb3a4fe8e1e15f6e658
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGLC2 IGLC3 IGLC6 IGLV5-45	6.98e-05	189	52	4	a1bda6ed5c52a5d33d229018cb5982cae6305533
ToppCell	356C-Lymphocytic-Plasma_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	IGLC2 IGLC3 IGLC6 IGLV5-45	6.98e-05	189	52	4	0994aba7a44577a8943af237c9c3575502d0584c
ToppCell	wk_08-11-Endothelial-Lymph_endothelial-Lymphatic_endo\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	BMX HOXD10 SHE TM4SF18	7.12e-05	190	52	4	279c5f68b993dc7adbf9aa69fffb1321cdebc48a
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BMX BST1 PAK5 SHE	7.12e-05	190	52	4	9b0ad888eb20acc011904d8593bc32bdef18d050
ToppCell	wk_08-11-Endothelial-Lymph_endothelial\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	BMX HOXD10 SHE TM4SF18	7.12e-05	190	52	4	d7f1dc032d161529559e01832d1a3112c6f6cc1a
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BMX BST1 PAK5 SHE	7.41e-05	192	52	4	c157981b9a179925edcaabc0cb3b8805f0929004
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	CYLD IGLC2 IGLC3 HSF2	7.41e-05	192	52	4	aee6522d25e012231cdb905ce047295cb64d6e82
ToppCell	COVID-19_Severe-Lymphoid_T/NK-CD4+_T_activated\|COVID-19_Severe / Disease group, lineage and cell class	CYLD ANK3 IGLC2 IGLC3	7.56e-05	193	52	4	beb862d38b88572836b0a797c8efef7a2492e0b9
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CYLD ANK3 IGLC2 IGLC3	7.56e-05	193	52	4	f4310faa13fc8ce99a217e2d1c9cc733683797a1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CYLD ANK3 IGLC2 IGLC3	7.56e-05	193	52	4	2901d7a9672a8cf70c9f1c752685b45e4d79ac70
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CYLD ANK3 IGLC2 IGLC3	7.56e-05	193	52	4	f8af695457d2a0a911a5ac491742465864ebda37
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	CYLD ANK3 IGLC2 IGLC3	7.56e-05	193	52	4	089aece40130034a89a5213be778f10b0787eeba
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage-immature_B_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	IGLC2 IGLC3 IGLC6 IGLV5-45	7.87e-05	195	52	4	ecaaa3d071e763c40d05d088fbf9e8ca06f78f47
ToppCell	COVID-19_Moderate-CD4+_T_naive\|World / disease group, cell group and cell class	CYLD ANK3 IGLC2 IGLC3	7.87e-05	195	52	4	38d65cf0895f7a99d789ec3dcbd56a7506706d38
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGLC2 IGLC3 IGLC6 IGLV5-45	7.87e-05	195	52	4	f3f7f1a77a1edd2b50a8211c76fe289738eb04cf
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	BMX HOXD10 SHE TM4SF18	8.35e-05	198	52	4	306e28d31fd587409a12dcccc6b2abd7dc9c2e0a
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	TJP1 EXPH5 DHX29 DNTTIP2	8.35e-05	198	52	4	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	AGBL4 ANK3 PAK5 PGM2L1	8.35e-05	198	52	4	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BMX TJP1 CHSY1 SHE	8.35e-05	198	52	4	d1f54ed3ef5e05ebda7da999e172d168dc6802cd
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_lymphatic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	BMX HOXD10 SHE TM4SF18	8.35e-05	198	52	4	05429f18e1d74880c1835568c86177f661b3477a
ToppCell	PSB-critical-LOC-Epithelial\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ANK3 TJP1 EXPH5 PGM2L1	8.51e-05	199	52	4	58dcb0eedafa8629585dc99e53147e2287f49689
ToppCell	Parenchyma_COVID-19-Endothelial-TX-Lymphatic\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	BMX HOXD10 SHE TM4SF18	8.51e-05	199	52	4	88f33b8dcd837abfa1d12c28719e073a7da6e979
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BMX HOXD10 SHE TM4SF18	8.51e-05	199	52	4	64b19aff72e2a109cb5857cb248bd4712dd49b43
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BMX HOXD10 SHE TM4SF18	8.51e-05	199	52	4	2b9e1e069b36b3a61cc3e384f4523687b0e03905
ToppCell	Parenchyma_COVID-19-Endothelial-TX-Endothelial-1\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	SHE IGLC2 IGLC3 TM4SF18	8.68e-05	200	52	4	b65fb8d378abd91cdabf5faac5f4b90d527f8c44
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SHE IGLC2 IGLC3 TM4SF18	8.68e-05	200	52	4	2cb6e35add34b9dc564ebcf5d3cbc761325ca9f4
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_T_activated\|COVID-19_Severe / Disease, condition lineage and cell class	CYLD ANK3 IGLC2 IGLC3	8.68e-05	200	52	4	deeed668b129e66156b5f6abe1a07a9bf842a14d
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	SHE IGLC2 IGLC3 TM4SF18	8.68e-05	200	52	4	27507c4b41d45c7cc50e4993169c0302be22ee34
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_STALK\|Hippocampus / BrainAtlas - Mouse McCarroll V32	BMX BST1 SHE	5.71e-04	139	52	3	34398a6f21a1e670497655a7bb7f3cde9e117560
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2\|Hippocampus / BrainAtlas - Mouse McCarroll V32	BMX BST1 SHE	5.71e-04	139	52	3	450c4152c9fe4ec503271bb3cf93739918c59509
ToppCell	metastatic_Lymph_Node-B_lymphocytes-Plasma_cells\|metastatic_Lymph_Node / Location, Cell class and cell subclass	IGLC2 IGLC3 IGLC6	6.07e-04	142	52	3	5ba3a33c2ee20be8baaed97536ca6e9d1de6752f
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-4\|TCGA-Brain / Sample_Type by Project: Shred V9	AGBL4 CDKL5 ATXN7L3	6.98e-04	149	52	3	ff472ad641efd655905e99a9a4cacd5245ab8854
ToppCell	COVID-19_Severe-multiplets\|COVID-19_Severe / disease group, cell group and cell class	IGLC2 IGLC3 MGAM2	7.40e-04	152	52	3	451745151322c2fcea22dbb3dba681e12634a510
ToppCell	Transplant_Alveoli_and_parenchyma-Immune-B_cells\|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X	IGLC2 IGLC3 IGLC6	7.40e-04	152	52	3	66f9190de155251a63a7a669374f342a75d22ea0
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IGLC2 IGLC3 IGLC6	7.54e-04	153	52	3	3724dd498b982be693ddff9cea7671863acf3ff8
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IGLC2 IGLC3 IGLC6	7.54e-04	153	52	3	d810fc5aff28449ce79b4148558b260878a2c696
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-5\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGLC2 IGLC3 ZNF543	7.69e-04	154	52	3	020697ae8463b18f9b4270c404f52ce4c0e90135
ToppCell	343B-Lymphocytic-Plasma_cell-\|343B / Donor, Lineage, Cell class and subclass (all cells)	IGLC2 IGLC3 IGLC6	8.13e-04	157	52	3	554ddbaf83f5d6eb4669c673efdbb28fd87e2ba8
ToppCell	343B-Lymphocytic-Plasma_cell\|343B / Donor, Lineage, Cell class and subclass (all cells)	IGLC2 IGLC3 IGLC6	8.13e-04	157	52	3	2cb3deb5313ce734710c601935ca318e4179077e
ToppCell	ASK440-Immune-B_cell\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	IGLC2 IGLC3 FOXN3	8.43e-04	159	52	3	d31eb59c1b5948df721b829b9a7e806f27cbd41c
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAK5 LAMA1 CCDC7	8.58e-04	160	52	3	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-naive_B_cell\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	IGLC2 IGLC3 IGLC6	8.58e-04	160	52	3	bfbac5ed3273b4430314c6c25cdc1bf0c42b27a1
ToppCell	Mild-Lymphoid-Plasma-\|Mild / Condition, Lineage, Cell class and cell subclass	SHE IGLC2 IGLC3	8.58e-04	160	52	3	aa79848913910c01249d6cacf4ed53ec0e4f5c3d
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAK5 LAMA1 CCDC7	8.58e-04	160	52	3	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	lymphoid-T_cell-pro-T_cell\|T_cell / Lineage, cell class and subclass	IGLC2 IGLC3 IGLC6	8.58e-04	160	52	3	66fe86d2f37983761141e5bb3de127f0b4bb0951
ToppCell	Mild-Lymphoid-Plasma\|Mild / Condition, Lineage, Cell class and cell subclass	SHE IGLC2 IGLC3	8.58e-04	160	52	3	7fdb849f5caf5a127a2582326215e11f8eb4fa0e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	IGLC2 IGLC3 IGLC6	8.90e-04	162	52	3	8ed9149ff53b285591354057055d072b203a47c8
ToppCell	368C-Lymphocytic-Plasma_cell\|368C / Donor, Lineage, Cell class and subclass (all cells)	IGLC2 IGLC3 IGLC6	8.90e-04	162	52	3	f945688815229c8386cbcbf46deee7df316fa8d3
ToppCell	368C-Lymphocytic-Plasma_cell-\|368C / Donor, Lineage, Cell class and subclass (all cells)	IGLC2 IGLC3 IGLC6	8.90e-04	162	52	3	c21a54310b239d999bbc9d8fb5e8fda16e0bc336
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	IGLC2 IGLC3 IGLC6	8.90e-04	162	52	3	7a05b05a33e1309fb5c0a8171db105ae68491815
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-13\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	WDHD1 IGLC2 IGLC3	8.90e-04	162	52	3	28b3a6ae5519a267eefb70436d3190a387d027b9
ToppCell	COVID-19_Severe-multiplets\|World / disease group, cell group and cell class	IGLC2 IGLC3 MGAM2	9.06e-04	163	52	3	6db4271c2d47a9c333964f36d2c32207115e52cd
ToppCell	metastatic_Brain-B_lymphocytes-Undetermined\|metastatic_Brain / Location, Cell class and cell subclass	IGLC2 SPRTN ZBTB24	9.06e-04	163	52	3	4eac7fd8acdb7f09ce739335f22a879f9b8febfb
ToppCell	Healthy_Control-Lymphoid-Plasma\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	IGLC2 IGLC3 ZBTB24	9.06e-04	163	52	3	2913ccdd4613472cd82077d4993e1d9f8b223398
Disease	Progeria	ANK3 SPRTN	2.58e-05	5	48	2	C0033300
Disease	Carcinoma in situ of endometrium	PMS1 MAX	3.90e-04	18	48	2	C0346191
Disease	Malignant neoplasm of endometrium	PMS1 MAX	3.90e-04	18	48	2	C0007103
Disease	body surface area	AGBL4 UBN1 MAX CHSY1 TRIP12 ZBTB24	5.90e-04	643	48	6	EFO_0022196
Disease	Growth Disorders	ATP7A AFF4	1.58e-03	36	48	2	C0018273
Disease	Metastatic melanoma	CDKL5 PAK5	3.51e-03	54	48	2	C0278883

Protein segments in the cluster

Peptide	Gene	Start	Entry
QKNDSGLDYQSCPTS	BST1	146	Q10588
ENQSYKSPSETHDKS	CCDC7	521	Q96M83
NESKKNYGSQPPSSS	BMX	196	P51813
QNSDSGSTNNYKSLK	CCDC144CP	406	Q8IYA2
KQGPKIYSFNSTNDS	DHX29	61	Q7Z478
ELSNSDPFKYNNSTG	ATXN7L3	176	Q14CW9
SVDSNIPSSQGYKKE	AFF4	491	Q9UHB7
KSSEGSQQRSPSYTN	ATP7A	261	Q04656
KKDYPSNTTSSTSNS	RBM23	31	Q86U06
KLPQSQSKSGYSSSS	PAK5	356	Q9P286
PSSDNSLYTNAKGST	MAX	116	P61244
YKSDSDKQQGSGVPS	IGLV5-39	71	A0A0G2JS06
SKNSNYEPYNNGSLK	MGAM2	411	Q2M2H8
VTTGYDSSQPNKKSV	PGM2L1	531	Q6PCE3
SESDNSKSPCNNGFK	OBI1	546	Q5W0B1
DKQNYSTREQSGTPS	EXPH5	1296	Q8NEV8
SQVTKSSPEQSYQGD	GPRC5C	301	Q9NQ84
PSNKSSNDDLTNAGY	BICRAL	26	Q6AI39
PKEDHNYSSAKSSNA	FOXN3	331	O00409
TTPSKQSNNKYAASS	IGLC2	56	P0DOY2
TTPSKQSNNKYAASS	IGLC3	56	P0DOY3
TTPSKQSNNKYAASS	IGLC6	56	P0CF74
GKTQEYNNSPEGSST	HOXD10	161	P28358
SNYPNSKGDKKSSVN	AGBL4	481	Q5VU57
QNSDSGSTNNYKSLK	CCDC144B	456	Q3MJ40
KNGKEYSSQSPTSSS	ANK3	2616	Q12955
AIPTSNSYSKKTQSN	MARK2	416	Q7KZI7
YPDCKSSANTNSSEG	HOXC8	111	P31273
QNSDSGSTNNYKSLK	CCDC144A	456	A2RUR9
YTLNGSSVDSQPQSK	CYLD	356	Q9NQC7
TKTYQASSQPGSTSK	CDKL5	381	O76039
NKVESSGKNYSNVDT	PMS1	371	P54277
ESGSSIAEKSYQNSP	MED1	1466	Q15648
YKASTNIQDTEGNTP	PSMD10	161	O75832
ASTYNKNSNIPGSSA	HNRNPUL1	726	Q9BUJ2
NPTDYINNTKSENKG	HSF2	401	Q03933
PSSNSTEKKYFSETN	TAS2R40	176	P59535
YKSDSDKQQGSGVPS	IGLV5-45	71	A0A087WSX0
AYNTSNKETKQGETP	LAMA1	2406	P25391
DPSYSKSSNNNGSVR	CHSY1	786	Q86X52
LYTSAPNTSQGKDNS	DNTTIP2	426	Q5QJE6
SSPDENNGQSKSKYC	ZBTB14	131	O43829
SVKQVYTPKGADNSS	UCP3	101	P55916
PNGQTSYASSNKLTN	TM4SF18	31	Q96CE8
KPGQNSFSKSTNSSD	WDHD1	881	O75717
KTGSSAQKSLSEYNN	POLR2A	751	P24928
QIKSSGNDPKYSTTT	SPRTN	426	Q9H040
GNDPKYSTTTAQNSS	SPRTN	431	Q9H040
PKTEDGQASQSRYSK	ZBTB24	241	O43167
NQSNFSSYSSKGKPP	TJP1	1391	Q07157
GSSYKNNPFASSISK	UBN1	896	Q9NPG3
TKDLSQSSYPGDNTK	ZNF543	71	Q08ER8
KPDFTKNSQVGSDNS	ZNF280C	126	Q8ND82
DTQEKNGKSNYPSSS	SHE	151	Q5VZ18
NPLANSNTSGYSESK	TRIP12	801	Q14669